Community Schedule

Enter at least 4 characters

4 results showing for: 'phenobarbitone'

  1. Various
Pharmacy Services    Medsafe Data Sheets   New Zealand Formulary.   Hospital Medicines List.   PDF Schedule - Refer from page 274.
  • 3 to 6 month supply. Brand switch fee
    • Brand Fully subsidised brand. BSF Noumed Phenobarbitone
    • Pharmacode2684756
    • Subsidy $4.50
    • Measure / Qty per 1
    • Brand Fully subsidised brand. BSF Eltroxin
    • Pharmacode2689251
    • Subsidy $4.50
    • Measure / Qty per 1
    • Brand Fully subsidised brand. BSF Pomolide
    • Pharmacode2689278
    • Subsidy $4.50
    • Measure / Qty per 1
    • Brand Fully subsidised brand. BSF Lenalidomide (Viatris)
    • Pharmacode2689286
    • Subsidy $4.50
    • Measure / Qty per 1
    • Brand Fully subsidised brand. BSF Alyacen
    • Pharmacode2692112
    • Subsidy $4.50
    • Measure / Qty per 1
    • Brand Fully subsidised brand. BSF Norethinderone – CDC
    • Pharmacode2692120
    • Subsidy $4.50
    • Measure / Qty per 1
    • Brand Fully subsidised brand. BSF Continuous glucose monitor (standalo
    • Pharmacode2692139
    • Subsidy $4.50
    • Measure / Qty per 1
    • Brand Fully subsidised brand. BSF Continuous glucose monitor (interope
    • Pharmacode2692147
    • Subsidy $4.50
    • Measure / Qty per 1
    (BSF Noumed Phenobarbitone Brand switch fee to be delisted 01 November 2024)
    (BSF Eltroxin Brand switch fee to be delisted 01 December 2024)
    (BSF Pomolide Brand switch fee to be delisted 01 December 2024)
    (BSF Lenalidomide (Viatris) Brand switch fee to be delisted 01 December 2024)
    (BSF Alyacen Brand switch fee to be delisted 01 January 2025)
    (BSF Norethinderone – CDC Brand switch fee to be delisted 01 January 2025)
    (BSF Continuous glucose monitor (standalo Brand switch fee to be delisted 01 January 2025)
    (BSF Continuous glucose monitor (interope Brand switch fee to be delisted 01 January 2025)

    May only be claimed once per patient.

  1. Control of Epilepsy
Phenobarbitone    Medsafe Data Sheets   New Zealand Formulary.   Hospital Medicines List.   PDF Schedule - Refer from page 136.
  • Tab 15 mg - Noumed Phenobarbitone: Brand switch fee payable.
    • Brand Fully subsidised brand. Noumed Phenobarbitone
    • Pharmacode2647524
    • Subsidy $248.50
    • Measure / Qty per 500
  • Tab 30 mg
    • Brand Fully subsidised brand. Noumed Phenobarbitone
    • Pharmacode2647532
    • Subsidy $398.50
    • Measure / Qty per 500

For phenobarbitone oral liquid refer Standard Formulae, page 277

  1. Sedatives and Hypnotics
Phenobarbitone sodium    Medsafe Data Sheets   New Zealand Formulary.   Hospital Medicines List.   PDF Schedule - Refer from page 147.
- Special Authority SA1386 -- Retail pharmacy
  • Inj 200 mg per ml, 1 ml ampoule
    • Brand Fully subsidised brand. Max Health Unapproved medicine supplied under Section 29.
    • Pharmacode2437856
    • Subsidy $113.37
    • Measure / Qty per 10
SA1386 – Phenobarbitone
  1. Extemporaneously Compounded Preparations and Galenicals
Phenobarbitone sodium    Medsafe Data Sheets   New Zealand Formulary.   Hospital Medicines List.   PDF Schedule - Refer from page 278.
  • Powder - Only in combination
    • Brand Fully subsidised brand. MidWest
    • Pharmacode2152002
    • Subsidy $325.00
    • Measure / Qty per 100 g
    • Brand Fully subsidised brand. MidWest
    • Pharmacode2338963
    • Subsidy $52.50
    • Measure / Qty per 10 g

    Only in children up to 12 years

  • Rectangle page icon symoblising a PDF. PDF
  • A tick icon. Fully subsidised
  • An oval with the number 29 in it. Unapproved medicine under Section 29
  • An asterisk symbol. 3 or 6 months should be dispensed at once
  • Two duplicate pages icon. Click to copy
  • A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
  • OP Original pack
  • Sole Subsidised Supply



Email enquiry@pharmac.govt.nz to provide feedback: compliments, suggestions and complaints.